Brand Intelligence Graph
Company Overview
About Aktis Oncology
Aktis Oncology is a Boston-based clinical-stage oncology company developing alpha-emitting radiopharmaceuticals against prevalent solid tumors. The company completed a $318 million IPO in January 2026 — the first significant biotech IPO of 2026 — pricing 17.65 million shares at $18 each on the Nasdaq under ticker AKTS. Eli Lilly stepped in to purchase $100 million of the offering.
Business Model & Competitive Advantage
The company's lead candidate, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, the same protein that Pfizer's bladder cancer drug Padcev binds to. Aktis's approach uses alpha-emitting isotopes which can hit tumor targets outside the scope of other radiopharmaceuticals. A second candidate, Ac-AKY-2519, targets B7-H3 expressing tumors with an IND filing planned for 2026.
Competitive Landscape 2025–2026
Aktis's IPO ranks as the sector's third-largest since the start of 2024, trailing only offerings from Kyverna Therapeutics and CG Oncology, and its successful debut signals renewed public market interest in companies with differentiated platforms and clear clinical milestones in precision oncology.
Key Differentiators
Strong Challenger
Aktis Oncology is an established challenger with significant market presence and competitive offerings in Healthcare & Life Sciences.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Compare Aktis Oncology with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Aktis Oncology? Verify your company email to claim this profile and keep its description, products, and FAQs up to date.
Claim Aktis Oncology Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Aktis Oncology vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →